• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病患者戒烟的艰难历程:为何精良的“工具”至关重要。

The uphill journey of smoking cessation in chronic obstructive pulmonary disease: why a well-built vehicle matters.

作者信息

Jakobsen Rasmus Kragh, Farver-Vestergaard Ingeborg, Løkke Anders

机构信息

Department of Medicine, Lillebaelt Hospital, Vejle, Denmark.

Department of Regional Health Research, University of Southern Denmark, Odense, Denmark.

出版信息

Front Health Serv. 2025 Sep 10;5:1659295. doi: 10.3389/frhs.2025.1659295. eCollection 2025.

DOI:10.3389/frhs.2025.1659295
PMID:41001118
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12457438/
Abstract

INTRODUCTION

Smoking cessation remains among the most effective interventions for improving outcomes in patients with chronic obstructive pulmonary disease (COPD). Quitting smoking slows disease progression, reduces morbidity, improves quality of life and increases life expectancy. However, a substantial proportion of patients with COPD continue to smoke, and generic cessation strategies often fall short in this population. While most cessation research targets "healthy" smokers, individuals with COPD face additional challenges - including higher nicotine dependence and psychological comorbidities - that complicate quit attempts.

METHODS

This mini-review summarises randomised controlled trials (RCTs) investigating smoking cessation interventions in COPD.

RESULTS

Our study reveals wide variability in the intensity, duration and components of interventions, with only a minority achieving long-term abstinence. Notably, two high-performing studies stand out for their comprehensive, long-term and individualised approaches. These findings suggest that success in smoking cessation for patients with COPD relies not only on the right intervention components but also on the construction, durability and sustained support.

CONCLUSION

To support and sustain smoking cessation among patients with COPD, multicomponent, high-intensity and long-duration interventions tailored to individual needs appear to be required, with an emphasis on ongoing support and frequent follow-up.

摘要

引言

戒烟仍然是改善慢性阻塞性肺疾病(COPD)患者预后最有效的干预措施之一。戒烟可减缓疾病进展、降低发病率、提高生活质量并延长预期寿命。然而,相当一部分COPD患者仍继续吸烟,通用的戒烟策略在这一人群中往往效果不佳。虽然大多数戒烟研究针对的是“健康”吸烟者,但COPD患者面临额外的挑战,包括更高的尼古丁依赖和心理合并症,这使得戒烟尝试变得更加复杂。

方法

本小型综述总结了调查COPD患者戒烟干预措施的随机对照试验(RCT)。

结果

我们的研究表明,干预措施的强度、持续时间和组成部分存在很大差异,只有少数能实现长期戒烟。值得注意的是,两项表现出色的研究因其全面、长期和个性化的方法脱颖而出。这些发现表明,COPD患者戒烟的成功不仅取决于正确的干预组成部分,还取决于干预措施的构建、持续性和持续支持。

结论

为了支持和维持COPD患者的戒烟,似乎需要针对个体需求的多成分、高强度和长期干预措施,重点是持续支持和频繁随访。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db47/12457438/fb5e023f7c11/frhs-05-1659295-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db47/12457438/fb5e023f7c11/frhs-05-1659295-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db47/12457438/fb5e023f7c11/frhs-05-1659295-g001.jpg

相似文献

1
The uphill journey of smoking cessation in chronic obstructive pulmonary disease: why a well-built vehicle matters.慢性阻塞性肺疾病患者戒烟的艰难历程:为何精良的“工具”至关重要。
Front Health Serv. 2025 Sep 10;5:1659295. doi: 10.3389/frhs.2025.1659295. eCollection 2025.
2
Effectiveness and cost-effectiveness of computer and other electronic aids for smoking cessation: a systematic review and network meta-analysis.计算机和其他电子戒烟辅助手段的有效性和成本效益:系统评价和网络荟萃分析。
Health Technol Assess. 2012;16(38):1-205, iii-v. doi: 10.3310/hta16380.
3
Strategies to improve smoking cessation rates in primary care.提高初级保健中戒烟率的策略。
Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD011556. doi: 10.1002/14651858.CD011556.pub2.
4
Interventions to reduce harm from continued tobacco use.减少持续吸烟危害的干预措施。
Cochrane Database Syst Rev. 2016 Oct 13;10(10):CD005231. doi: 10.1002/14651858.CD005231.pub3.
5
Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis.戒烟药物和电子烟:系统评价、网络荟萃分析和成本效益分析。
Health Technol Assess. 2021 Oct;25(59):1-224. doi: 10.3310/hta25590.
6
Nicotine receptor partial agonists for smoking cessation.用于戒烟的尼古丁受体部分激动剂。
Cochrane Database Syst Rev. 2016 May 9;2016(5):CD006103. doi: 10.1002/14651858.CD006103.pub7.
7
Behavioural interventions for smoking cessation: an overview and network meta-analysis.行为干预戒烟:综述和网络荟萃分析。
Cochrane Database Syst Rev. 2021 Jan 4;1(1):CD013229. doi: 10.1002/14651858.CD013229.pub2.
8
Psychosocial interventions for smoking cessation in patients with coronary heart disease.冠心病患者戒烟的心理社会干预措施。
Cochrane Database Syst Rev. 2015 Jul 6;2015(7):CD006886. doi: 10.1002/14651858.CD006886.pub2.
9
Interventions to reduce tobacco use in people experiencing homelessness.减少无家可归人群吸烟的干预措施。
Cochrane Database Syst Rev. 2020 Dec 3;12(12):CD013413. doi: 10.1002/14651858.CD013413.pub2.
10
Vesicoureteral Reflux膀胱输尿管反流

本文引用的文献

1
Knowledge of and Attitudes Towards Standard Care in Patients with COPD.慢性阻塞性肺疾病患者对标准治疗的认知与态度
Int J Chron Obstruct Pulmon Dis. 2025 Apr 29;20:1287-1297. doi: 10.2147/COPD.S489395. eCollection 2025.
2
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary.慢性阻塞性肺疾病全球倡议2023年报告:GOLD执行摘要。
Arch Bronconeumol. 2023 Apr;59(4):232-248. doi: 10.1016/j.arbres.2023.02.009. Epub 2023 Mar 1.
3
Effects of different interventions on smoking cessation in chronic obstructive pulmonary disease patients: A systematic review and network meta-analysis.
不同干预措施对慢性阻塞性肺疾病患者戒烟效果的影响:系统评价和网络荟萃分析。
Int J Nurs Stud. 2022 Dec;136:104362. doi: 10.1016/j.ijnurstu.2022.104362. Epub 2022 Sep 14.
4
Developments in smoking cessation interventions for patients with chronic obstructive pulmonary disease in the past 5 years: a scoping review.过去 5 年中慢性阻塞性肺疾病患者戒烟干预措施的进展:范围综述。
Expert Rev Respir Med. 2022 Jul;16(7):749-764. doi: 10.1080/17476348.2022.2108797. Epub 2022 Aug 11.
5
Medication-assisted quit rates in participants with smoking-related diseases in EAGLES: Post hoc analyses of a double-blind, randomized, placebo-controlled clinical trial.EAGLES研究中患有吸烟相关疾病参与者的药物辅助戒烟率:一项双盲、随机、安慰剂对照临床试验的事后分析
Tob Induc Dis. 2022 May 10;20:46. doi: 10.18332/tid/146567. eCollection 2022.
6
Behavioural interventions for smoking cessation: an overview and network meta-analysis.行为干预戒烟:综述和网络荟萃分析。
Cochrane Database Syst Rev. 2021 Jan 4;1(1):CD013229. doi: 10.1002/14651858.CD013229.pub2.
7
Updated methodological guidance for the conduct of scoping reviews.范围综述实施的更新方法学指南。
JBI Evid Synth. 2020 Oct;18(10):2119-2126. doi: 10.11124/JBIES-20-00167.
8
The long-term outcomes of tobacco control strategies based on the cognitive intervention for smoking cessation in COPD patients.基于认知干预的戒烟策略对 COPD 患者的长期影响。
Respir Med. 2020 Oct;172:106155. doi: 10.1016/j.rmed.2020.106155. Epub 2020 Sep 12.
9
Effect of Early Initiation of Varenicline on Smoking Cessation in COPD Patients Admitted for Exacerbation: The Save Randomized Clinical Trial.早期应用伐尼克兰对 COPD 加重期患者戒烟的影响:Save 随机临床试验。
COPD. 2020 Feb;17(1):7-14. doi: 10.1080/15412555.2019.1703928. Epub 2019 Dec 19.
10
It is time for the world to take COPD seriously: a statement from the GOLD board of directors.全球慢性阻塞性肺疾病倡议(GOLD)董事会声明:是时候让世界认真对待慢性阻塞性肺疾病了。
Eur Respir J. 2019 Jul 4;54(1). doi: 10.1183/13993003.00914-2019. Print 2019 Jul.